Medical device recalls and the FDA approval process

Area of Science:

• Medical Device Regulation
• Public Health
• Regulatory Science

Background:

• The US Food and Drug Administration (FDA) uses two main regulatory pathways for medical devices: Premarket Approval (PMA) and the 510(k) process.
• The PMA process involves rigorous clinical testing and inspections, while the 510(k) process requires devices to be substantially equivalent to existing predicate devices, often for lower-risk devices.

Purpose of the Study:

• To analyze the regulatory pathways of high-risk medical devices recalled between 2005 and 2009.
• To determine if recalled devices were approved via PMA, 510(k), or were exempt from FDA review.

Main Methods:

• Analysis of the FDA's high-risk List of Device Recalls from 2005 to 2009.
• Categorization of recalled devices based on their FDA regulatory pathway: PMA, 510(k), or exempt.

Main Results:

• Of 113 high-risk recalls, 71% were cleared through the 510(k) process, 19% through PMA, and 7% were exempt.
• Cardiovascular devices were the largest recall category (31%), with most cleared via 510(k).
• Other high-risk recalls were concentrated in general hospital, anesthesiology, clinical chemistry, neurology, and ophthalmology.

Conclusions:

• A significant majority (78%) of recalled medical devices posing serious risks were cleared through the less rigorous 510(k) process or were exempt from review.
• Findings indicate a potential need for reform in the medical device regulatory process to enhance patient safety.